-+ 0.00%
-+ 0.00%
-+ 0.00%

ETERNA THERAPEUTICS ANNOUNCES POSITIVE PRECLINICAL STUDY RESULTS ON LEAD PRODUCT ERNA-101 IN OVARIAN CANCER

Reuters·01/14/2025 13:30:01

Please log in to view news